Media Mentions
2011
“Seed Capital: Beyond Angels And VC”
Life Science Leader, January 2011
Paul DeStefano said about the trend of venture funding that “the United States is seeing more tranches than in the past.” Mr. DeStafano noted that “foundations are applying their [venture] funds differently than in the past,” making larger, but fewer, grants. He added that one of his life science clients just received a family foundation grant that funds all clinical trials up to $50 million.
Paul R. DeStefano, Life Sciences & Medical Products, Life Sciences - Corporate
2010
Peter Townshend was quoted by the San Diego Union-Tribune on March 7, in a story that discussed the drop in venture capital investment funding since 2007. “The consensus is that we’ll be seeing some underperforming venture funds going under this year and next,” Mr. Townshend said about the ongoing decline. He added that if the economy doesn’t improve, “you could see pension funds, which are the biggest backers of venture capital, decide that they’re not worth the risk, and that would be a true catastrophe for the venture market.” Mr. Townshend also noted that proposals for large companies like pharmaceuticals to step into the funding gap would not work in such other fields as telecom or software.
, Corporate, Life Sciences - Corporate
2009
Paul DeStefano was quoted in a December 28 Daily Journal story that reviewed the possible effect of health reform legislation on business combinations in the health care industry. He noted that reform bills have had little effect on mergers and acquisitions involving large pharmaceutical companies, mainly because those deals take too long to respond to rapidly changing legislative developments. “The cycle on product development is so long, so uncertain and so expensive, you can’t turn that ship based on a change made today,” Mr. DeStefano said.
Paul R. DeStefano, Health, Life Sciences & Medical Products Litigation, Life Sciences - Corporate, Life Sciences - Health
Den White was quoted on February 7, 2009 in Middle East and Africa Pharma and Healthcare Insights on an article regarding the resilience of the pharmaceutical sector in terms of M&A, with corporate activity continuing in spite of the global financial situation. "In healthcare and life sciences there are still some positive things happening. We have an ageing population and so favorable demographics continue to drive healthcare, and then on top of that we have the Obama administration, looking to roll out universal healthcare in the US," said Mr. White. "There continue to be breakthrough advances in medical devices that are impacting the delivery of medical care and impacting information technology in the healthcare industry," he added.
